bioAffinity Technologies prices $4M ATM private placement with warrants
bioAffinity Technologies (BIAF) prices a ~$4.0M-at-gross private placement at-the-market selling 8.46M shares (or pre-funded warrants) plus warrants for up to 16.9M more shares, with warrants struck at $0.4727.
0M before fees — Expected to close August 14 — Company's lead product is CyPath Lung, a noninvasive early-stage lung cancer detection test